ATOS
Atossa Therapeutics (ATOS)
$83
About Atossa Therapeutics (ATOS)
Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.
Details
Daily high
$2.03
Daily low
$1.81
Price at open
$2.03
52 Week High
$19.35
52 Week Low
$1.81
Market cap
20.0M
Dividend yield
0.00%
Volume
469,934
Avg. volume
229,732
P/E ratio
-.46
Atossa Therapeutics News
Details
Daily high
$2.03
Daily low
$1.81
Price at open
$2.03
52 Week High
$19.35
52 Week Low
$1.81
Market cap
20.0M
Dividend yield
0.00%
Volume
469,934
Avg. volume
229,732
P/E ratio
-.46